Intratympanic Injection for Autoimmune Inner Ear Disease

NCT01526174 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

16

Enrollment

OTHER

Sponsor class

Stopped House Research no longer conducting research.

Conditions

Autoimmune Inner Ear Disease

Interventions

DRUG: Golimumab

Sponsor

House Research Institute

Collaborators

[object Object]